ERBB2 and cancer: MUC4 is aberrantly expressed in a variety of cancers, including breast tumors, and in this setting it can also induce phosphorylation of HER2, which results in inactivation of the pro-apoptotic pathway and in stimulation of pro-survival proteins (157).